Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 May;39(1):110-20.
doi: 10.1111/j.1476-5381.1970.tb09560.x.

Nonspecific supersensitivity of the guinea-pig vas deferens produced by decentralization and reserpine treatment

Nonspecific supersensitivity of the guinea-pig vas deferens produced by decentralization and reserpine treatment

D P Westfall. Br J Pharmacol. 1970 May.

Abstract

1. The sensitivity of the guinea-pig vas deferens to noradrenaline, histamine, methylfurmethide and potassium was examined in vitro following decentralization and reserpine treatment.2. One day after decentralization or administration of reserpine (1.0 mg/kg daily) the sensitivity of the vas deferens was not increased. After 5 days' treatment the muscle was supersensitive to all four stimulants.3. The magnitude of the sensitivity increase to an individual drug was the same following both chronic reserpine treatment and decentralization. However, the degree of supersensitivity differed for the four stimulants. The order of potentiation was noradrenaline>histamine>methylfurmethide>potassium.4. The magnitude of the supersensitivity was inversely correlated with the slope of the dose-response curves to the four agonists. The dose-response curve to potassium had the steepest slope, followed in order by methylfurmethide, histamine and noradrenaline.5. A hypothesis is presented to account for the inverse relationship between the slope of the dose-response curve and the degree of supersensitivity which follows reserpine treatment or decentralization.

PubMed Disclaimer

References

    1. J Pharmacol Exp Ther. 1968 Jan;159(1):91-7 - PubMed
    1. J Pharmacol Exp Ther. 1968 Dec;164(2):259-69 - PubMed
    1. Pharmacol Rev. 1961 Mar;13:17-37 - PubMed
    1. Acta Physiol Scand. 1962 Nov-Dec;56:376-80 - PubMed
    1. Pharmacol Rev. 1963 Jun;15:225-76 - PubMed

LinkOut - more resources